X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TTK HEALTHCARE - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON TTK HEALTHCARE BIOCON /
TTK HEALTHCARE
 
P/E (TTM) x 42.1 19.0 221.3% View Chart
P/BV x 7.3 4.9 149.9% View Chart
Dividend Yield % 0.2 0.6 26.6%  

Financials

 BIOCON    TTK HEALTHCARE
EQUITY SHARE DATA
    BIOCON
Mar-18
TTK HEALTHCARE
Mar-14
BIOCON /
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,188663 179.1%   
Low Rs305399 76.4%   
Sales per share (Unadj.) Rs68.7535.6 12.8%  
Earnings per share (Unadj.) Rs7.615.9 47.4%  
Cash flow per share (Unadj.) Rs14.020.0 69.8%  
Dividends per share (Unadj.) Rs1.004.00 25.0%  
Dividend yield (eoy) %0.10.8 17.8%  
Book value per share (Unadj.) Rs86.3137.6 62.7%  
Shares outstanding (eoy) m600.007.77 7,722.0%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.91.0 1,095.3%   
Avg P/E ratio x98.933.3 296.7%  
P/CF ratio (eoy) x53.426.5 201.4%  
Price / Book Value ratio x8.63.9 224.0%  
Dividend payout %13.225.1 52.8%   
Avg Mkt Cap Rs m447,9004,127 10,851.8%   
No. of employees `0006.11.7 360.0%   
Total wages/salary Rs m9,311607 1,534.9%   
Avg. sales/employee Rs Th6,705.82,436.7 275.2%   
Avg. wages/employee Rs Th1,514.2355.2 426.4%   
Avg. net profit/employee Rs Th736.972.5 1,015.8%   
INCOME DATA
Net Sales Rs m41,2344,162 990.8%  
Other income Rs m2,06261 3,369.3%   
Total revenues Rs m43,2964,223 1,025.2%   
Gross profit Rs m8,291197 4,206.5%  
Depreciation Rs m3,85132 12,148.3%   
Interest Rs m61530 2,056.9%   
Profit before tax Rs m5,887197 2,992.9%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56973 2,155.2%   
Profit after tax Rs m4,531124 3,657.0%  
Gross profit margin %20.14.7 424.6%  
Effective tax rate %26.737.0 72.0%   
Net profit margin %11.03.0 369.1%  
BALANCE SHEET DATA
Current assets Rs m41,4861,629 2,547.2%   
Current liabilities Rs m21,4131,058 2,024.3%   
Net working cap to sales %48.713.7 354.9%  
Current ratio x1.91.5 125.8%  
Inventory Days Days6430 214.8%  
Debtors Days Days9434 280.4%  
Net fixed assets Rs m50,661556 9,106.8%   
Share capital Rs m3,00078 3,861.0%   
"Free" reserves Rs m48,808878 5,557.1%   
Net worth Rs m51,8081,069 4,845.0%   
Long term debt Rs m17,898159 11,277.9%   
Total assets Rs m99,8972,399 4,163.4%  
Interest coverage x10.67.6 139.5%   
Debt to equity ratio x0.30.1 232.8%  
Sales to assets ratio x0.41.7 23.8%   
Return on assets %5.26.4 80.4%  
Return on equity %8.711.6 75.5%  
Return on capital %9.618.5 52.2%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m12,05833 36,650.5%   
Fx outflow Rs m7,34863 11,628.4%   
Net fx Rs m4,710-30 -15,549.7%   
CASH FLOW
From Operations Rs m6,621127 5,229.9%  
From Investments Rs m-6,840-146 4,684.9%  
From Financial Activity Rs m-2,39722 -10,945.2%  
Net Cashflow Rs m-2,6123 -104,480.0%  

Share Holding

Indian Promoters % 40.4 65.4 61.8%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 3.7 227.0%  
FIIs % 10.7 5.2 205.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 25.8 77.1%  
Shareholders   109,995 12,723 864.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Turn Volatile; Realty & IT Stocks Gain(12:30 pm)

Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the realty sector and IT sector.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Mar 20, 2019 02:29 PM

TRACK BIOCON

BIOCON - VENUS REMEDIES COMPARISON

COMPARE BIOCON WITH

MARKET STATS